CompareHolmuskvsKomodo Health
Customers evaluate the quality ofHolmusk's products using the following success metrics.
Overview
Holmusk is 8 yrs old and is based in Singapore.
Holmusk builds an evidence platform with behavioral health combining behavioral health databases with AI-powered analytics and digital solutions. Its proprietary technology powers data-driven medicine that leverages analytic and digital tools to address the need in healthcare and pharma-life science. The company was founded in 2015 and is based in Singapore.
Komodo Health is 9 yrs old and is based in United States.
Komodo Health operates a healthcare insights platform that brings transparency and market intelligence to healthcare and life sciences. Its platform use tools and brings together data across enterprises, public domain, and proprietary sources, enabling healthcare and life science industries. The company was founded in 2014 and is based in San Francisco, California.
Demo Video
Leadership
Nawal Roy(创始人,首席交货ecutive Officer)
Arif Nathoo(创始人,首席交货ecutive Officer)
Funding
Investors
Heritas Capital,Health Catalyst Capital Management
Dragoneer Investment Group,Coatue Management
Product
WhyHolmuskbeatsKomodo Health
- Komodo Health’s data are not as longitudinal as NeuroBlu’s. Komodo Health’s average patient journey data spans six years, in contrast to 20+ years of data represented within NeuroBlu. This significant advantage in longitudinality is critical to researchers in the pharmaceutical industry looking to prove trends in treatment and outcomes over time.
Information not available becauseKomodo Healthhas not claimed their profile.
Work forKomodo Health? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work forKomodo Health?
Claim your profile now.
Benefits
- Successful study completion: Clients utilize NeuroBlu data for a range of research studies. The ability to successfully complete a study and generate meaningful insights utilizing NeuroBlu data is a significant achievement both for clients and for Holmusk.
- Applicability of outcomes measures contained within NeuroBlu database: Many real world evidence databases, especially in behavioral health, contain outcomes measures that are used in clinical practice but not well-validated to use in research settings. Clients evaluate NeuroBlu data on the applicability of the outcomes measures contained in the data to translational research, as it proves the general utility of the data.
- Number and diversity of patients for a given behavioral health disorder: Researchers look for real world-evidence databases that contain a large and diverse patient population in order to drive statistical power in their studies. Clients evaluate NeuroBlu on its growth in particular disorders of note, such as Major Depressive Disorder and Schizophrenia, which have a high degree of clinical research activity. See attached information for a breakdown of how many patients NeuroBlu includes across disease areas of interest.
Products
NeuroBlu Database
The NeuroBlu database serves as the healthcare and pharmaceutical industry’s leading source for real-world behavioral health data. The database contains de-identified, longitudinal EHR data from over 1 million patients collected over more than 20 years from geographically diverse clinics across the U.S. The rapidly growing database includes data on patient diagnosis, treatment, hospitalization, and demographics, as well as nuanced information about external stressors, progress, treatment side effects, and more. NeuroBlu data fuel research for behavioral health conditions such as major depressive disorder, bipolar disorder, PTSD, ADHD, schizophrenia, substance-related disorders, and many others. The data have been used for a range of purposes, from assisting with early-stage drug research to driving public health impact.
Customers
Known Partners
Why They Buy
News & Analysis
Holmuskhas been mentioned in our research5times.
Komodo Healthhas been mentioned in our research5times.
Expert Collections
Mental Health Tech
1,285 items
This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.
Clinical Trials Tech
341 items
Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.
Unicorns- Billion Dollar Startups
1,208 items
Conference Exhibitors
5,302 items
Market
供应商根据resou ESP的排名位置rces and execution.
Holmusk is a Leader in Real-world data
The real-world data market refers to the collection and analysis of data from various sources, including electronic health records, claims data, and patient-generated data. This data is used to provide insights into real-world patient outcomes, treatment patterns, and disease progression. The market offers solutions that can help healthcare stakeholders make informed decisions about drug development, clinical trial design, and patient care. Real-world data can also be used to support regulatory decisions and health policy development. As the healthcare industry continues to shift towards value-based care, the demand for real-world data is expected to grow.